help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sartorio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sartorio, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 2 712
Copyright © 1998 by The Endocrine Society


Letters to the Editor

Different Impairment of Muscle Strength in Adults with Childhood-Onset and Acquired GH Deficiency

Alessandro Sartorio

Istituto Auxologico Italiano IRCCS, Milano, Italy Marco Narici Istituto di Tecnologie Biomediche Avanzate CNR, Milano, Italy Roberto Bottinelli Istituto di Fisiologia Umana Università di Pavia, Italy

We have read with interest the paper by Johansson et al. (1), concerning the positive effects exerted by GH treatment on isometric and isokinetic muscle strength in GH-deficient adults.

Because muscle mass is lower in adults with GH deficiency (GHD), and strength and power are proportional to muscle cross-sectional area (CSA) (2), it is expected that lower "absolute" force values, i.e. not normalized for muscle CSA, are found in GHD patients.

In agreement with previous reports (2, 3, 4), Johannsson et al. (1) actually found reduced isometric muscle strength compared with a group of healthy controls. These authors argue that a large variability in force/CSA exists in the literature, therefore questioning the validity of this parameter. Although it is true that variability in this parameter does exist, it has been shown (5) that these individual variations only exist if CSA is incorrectly measured, muscle voluntary activation is submaximal, and/or force is not measured at the optimum joint angle. In fact, once the CSA is correctly measured (physiological rather than anatomical CSA) and maximum voluntary contractions are truly maximal, the resulting values of force/CSA show good agreement with data on isolated animal muscle or human parallel-fibred muscle, in which the anatomical CSA corresponds to the physiological CSA.

The approach to use "absolute" values of force for comparison between patients and controls, although widely used in clinical studies, can be considered just acceptable in patients with normal body dimensions (i.e. height, weight, and BMI perfectly comparable with those of controls), but it is open to criticism in short-statured adults with childhood-onset GHD.

Once "absolute" quadriceps and hand-grip strengths are normalized for CSA, no differences are found between adults with childhood-onset GH deficiency (GHD) and controls (2, 6), thus suggesting that reduced muscular size and strength are likely attributed to a simple dimensional scaling.

Therefore, the discrepancy between our results (2, 6) and those reported by Johannsson et al. (1) is likely the result of the different populations (mixed population, especially acquired GHD in the Swedish study vs. childhood-onset in our works) compared with the use of force values normalized for CSA in our studies, other than to the higher percentage of multiple hormonal defects in their study population.

We believe that differences between childhood-onset and acquired syndrome might be more evident than previously believed; thus separate data analysis between patients with so different clinical histories and duration of GH-IGF-I lack seems essential.

Adults with childhood-onset GHD, lacking GH during the period of maximal growth, might fit better to the lack of GH than adults with acquired GHD. The latter, having normally developed body size with reduced muscle mass and strength, might undergo more dramatic consequences of muscle mass decrease than the former, who have a proportional decrease in body size, muscle mass and strength.

Patients with childhood-onset and acquired GHD might differ also as far as fiber-type proportion is concerned. In this respect, Rutherford et al. (3) provided some indirect evidence, based on lower half-relaxation time and rightward shift of force-frequency relation of quadriceps muscle, supporting the presence of a higher proportion of fast twitch, type 2 muscle fibers in acquired GHD patients. However, in a recent study in which direct measurements were performed on vastus lateralis biopsy samples, we demonstrated that fiber type distribution (i.e. myosin heavy chain isoform composition) and type 1 and 2A muscle fiber CSA/height2 in adults with childhood-onset GHD are not different from controls (7).

Therefore, what seems particularly relevant are the considerable differences between skeletal muscle structural and functional features of patients with childhood-onset and acquired GHD. These differences warrant attention and should be the focus of future investigation.

Footnotes

Received October 21, 1997. Address correspondence to: Alessandro Sartorio, MD, Endocrine Unit, Italian Institute for Auxology, Via Ariosto 13, 20145 Milan, Italy.

References

  1. Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA. 1997 Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 82:2877–2884.[Abstract/Free Full Text]
  2. Sartorio A, Narici M. 1994 Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength, and neural activation. Clin Physiol. 14:527–537.[Medline]
  3. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. 1991 Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol. 70:688–694.[Abstract/Free Full Text]
  4. Rutherford OM, Beshyah SA, Schott J, Watkins Y, Johnston DG. 1995 Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults. Clin Sci. 88:67–71.[Medline]
  5. Narici M, Landoni L, Minetti AE. 1992 Assessment of human knee extensor muscles stress from in vivo physiological cross-sectional area and strength measurements. Eur J Appl Physiol. 65:438–444.[CrossRef]
  6. Sartorio A, Narici M, Conti A, Monzani M, Faglia G. 1995 Quadriceps and hand-grip strength in adults with childhood-onset growth hormone deficiency. Eur J Endocrinol. 132:37–41.[Abstract/Free Full Text]
  7. Bottinelli R, Narici M, Pellegrino MA, et al. Contractile properties type distribution of quadriceps muscles in adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab. In press.



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. Kazlauskaite, A. T. Evans, C. V. Villabona, T. A. M. Abdu, B. Ambrosi, A. B. Atkinson, C. H. Choi, R. N. Clayton, C. H. Courtney, E. N. Gonc, et al.
Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4245 - 4253.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. J. Lipworth and M. B. Affrime
Mometason Furoate Levels
Chest, September 1, 2001; 120(3): 1034 - 1035.
[Full Text] [PDF]


Home page
QJMHome page
F.J.L. Kaplan, N.S. Levitt, and S.G. Soule
Primary hypoadrenalism assessed by the 1 {micro}g ACTH test in hospitalized patients with active pulmonary tuberculosis
QJM, September 1, 2000; 93(9): 603 - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. J. Nye, J. E. Grice, G. I. Hockings, C. R. Strakosch, G. V. Crosbie, M. M. Walters, and R. V. Jackson
Comparison of Adrenocorticotropin (ACTH) Stimulation Tests and Insulin Hypoglycemia in Normal Humans: Low Dose, Standard High Dose, and 8-Hour ACTH-(1-24) Infusion Tests
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3648 - 3655.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Oelkers
Comment on Comparison of the Low Dose Short Synacthen Test (1 {micro}g), the Conventional Dose Short Synacthen Test (250 {micro}g), and the Insulin Tolerance Test for Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients with Pituitary Disease
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2973 - 2973.
[Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sartorio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sartorio, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals